190
Participants
Start Date
January 31, 2016
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Imidazolyl ethanamide pentandioic acid
placebo
"GBOU VPO Kazan State Medical University of Ministry of Health of Russian Federation", Kazan'
"GBOU VPO Krasnoyarsk State Medical University n.a.n V.F. Voyno-Yasenetskogo of Ministry of Health of Russian Federation", Krasnoyarsk
"FGBU Scientific center of children health of the Ministry of Health of Russian Federation", Moscow
I.M. Sechenov First Moscow State Medical University, Moscow
"Moscow Budgetary Public Health Facility Infectious clinical hospital #1 of Moscow City Health Department", Moscow
"GBOU VPO Novosibirsk State Medical University of Ministry of Health of Russian Federation", Novosibirsk
Children's city outpatients clinic № 5, Perm
Children's city outpatients clinic № 4, Rostov-on-Don
"GBOU VPO Rostov State Medical University of Ministry of Health of Russian Federation", Rostov-on-Don
"FGBU Scientific Research Institute of Children's Infections, Federal Biomedical Agency", Saint Petersburg
"FGBOU VPO Mordov State University n.a. N.P. Ogarev", Saransk
"GBOU VPO Siberia State Medcial University of Ministry of Health of Russian Federation", Tomsk
"GBOU VPO Yaroslavl State Medical University of Ministry of Health of Russian Federation", Yaroslavl
Atlant Clinical Ltd.
OTHER
Valenta Pharm JSC
INDUSTRY